Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
01 1Siegfried USA, LLC
01 1Amobarbital Sodium
01 1Switzerland
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
NDC Package Code : 0792-0099
Start Marketing Date : 1967-03-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
100
PharmaCompass offers a list of Amobarbital Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amobarbital Sodium manufacturer or Amobarbital Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amobarbital Sodium manufacturer or Amobarbital Sodium supplier.
A Amylobarbitone, sodium deriv manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amylobarbitone, sodium deriv, including repackagers and relabelers. The FDA regulates Amylobarbitone, sodium deriv manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amylobarbitone, sodium deriv API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amylobarbitone, sodium deriv supplier is an individual or a company that provides Amylobarbitone, sodium deriv active pharmaceutical ingredient (API) or Amylobarbitone, sodium deriv finished formulations upon request. The Amylobarbitone, sodium deriv suppliers may include Amylobarbitone, sodium deriv API manufacturers, exporters, distributors and traders.
click here to find a list of Amylobarbitone, sodium deriv suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amylobarbitone, sodium deriv as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amylobarbitone, sodium deriv API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amylobarbitone, sodium deriv as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amylobarbitone, sodium deriv and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amylobarbitone, sodium deriv NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amylobarbitone, sodium deriv suppliers with NDC on PharmaCompass.
We have 1 companies offering Amylobarbitone, sodium deriv
Get in contact with the supplier of your choice:
